Effects of HAEG Regimen on Refractory Acute Leukemia
Jiacai Zhuo
Abstract
Jiacai Zhuo
Abstract
Objective To explore the therapeutic protocol for refractory acute leukemia.Methods Fifteen cases of refractory acute leukemia were treated with HAEG regimen,which consisted of Har1 mg/d(d1~10),Ara-C 30 mg/d(d1~14),VP-16 50 mg/d(d1~5),G-CSF 150 mg/d(d1~14).Results Eight patients(53.3%) achieved complete remission,2(13.4%)did partial remission,overall effective rate was 66.7%.Conclusion HAEG regimen in treatment of refractory acute leukemia is an effective means.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To explore the therapeutic protocol for refractory acute leukemia.Methods Fifteen cases of refractory acute leukemia were treated with HAEG regimen,which consisted of Har1 mg/d(d1~10),Ara-C 30 mg/d(d1~14),VP-16 50 mg/d(d1~5),G-CSF 150 mg/d(d1~14).Results Eight patients(53.3%) achieved complete remission,2(13.4%)did partial remission,overall effective rate was 66.7%.Conclusion HAEG regimen in treatment of refractory acute leukemia is an effective means.
Key concepts: Medicine, Refractory (planetary science), Regimen, Acute leukemia, Internal medicine, Complete remission, Leukemia, Gastroenterology